General Discussions

Patrick Spencer, RN, OCN, of Mount Sinai Medical Center, provides some important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.

The first day especially requires long hours of infusion. Spencer also recommends that the patient bring a caregiver with them. There can be infusion-related reactions that a patient might not normally report, such as a runny nose or itchy throat. If patients are prepared, however, and know to inform their clinicians, they can receive the proper medication to prevent such reactions from becoming severe.